Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis
Abstract Background Over the past three decades, allocation of foreign currency subsidies has been the primary strategy of various administrations in Iran to improve access to medicines. This strategy has resulted in several challenges, including stakeholder conflicts of interest. Objective To ident...
Saved in:
Main Authors: | Alireza Olyaaeemanesh (Author), Ebrahim Jaafaripooyan (Author), Akbar Abdollahiasl (Author), Majid Davari (Author), Seyyed Meysam Mousavi (Author), Mansoor Delpasand (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sixteen years of eHealth experiences in Iran: a qualitative content analysis of national policies
by: Seyyed Meysam Mousavi, et al.
Published: (2021) -
The Policy of Subsidy Elimination from Currency Allocated to Pharmaceutical Sector in Iran; Concerns of Patients, Payers, and Industry
by: Amir Hashemi, et al.
Published: (2023) -
Evaluation of Transparency to Improve Good Governance in Pharmaceutical Regulatory Sector of Iran
by: Yasaman Herandi, et al.
Published: (2020) -
An overview to pharmaceutical financing in Iran
by: Mehdi Varmaghani, et al.
Published: (2017) -
Eliciting the public preferences for pharmaceutical subsidy in Iran: a discrete choice experiment study
Published: (2021)